| 000 | 01651 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250512092127.0 | ||
| 264 | 0 | _c19741118 | |
| 008 | 197411s 0 0 eng d | ||
| 022 | _a0033-0620 | ||
| 024 | 7 |
_a10.1016/0033-0620(74)90032-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJewitt, D E | |
| 245 | 0 | 0 |
_aSpecial article. The role of beta-adrenergic blockade in myocardial infarction. _h[electronic resource] |
| 260 |
_bProgress in cardiovascular diseases _c |
||
| 300 |
_a421-38 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 |
_aAdrenal Glands _xphysiology |
| 650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xadministration & dosage |
| 650 | 0 | 4 |
_aAlprenolol _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aArrhythmias, Cardiac _xetiology |
| 650 | 0 | 4 |
_aAtrial Fibrillation _xdrug therapy |
| 650 | 0 | 4 |
_aAtrial Flutter _xdrug therapy |
| 650 | 0 | 4 |
_aBronchodilator Agents _xadverse effects |
| 650 | 0 | 4 |
_aHeart Block _xetiology |
| 650 | 0 | 4 | _aHemodynamics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 |
_aMyocardial Infarction _xcomplications |
| 650 | 0 | 4 |
_aPractolol _xmetabolism |
| 650 | 0 | 4 |
_aPropranolol _xadverse effects |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aSympathetic Nervous System _xphysiology |
| 650 | 0 | 4 |
_aSympathomimetics _xpharmacology |
| 650 | 0 | 4 |
_aVentricular Fibrillation _xdrug therapy |
| 700 | 1 | _aSingh, B N | |
| 773 | 0 |
_tProgress in cardiovascular diseases _gvol. 16 _gno. 4 _gp. 421-38 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0033-0620(74)90032-2 _zAvailable from publisher's website |
| 999 |
_c4158514 _d4158514 |
||